MRSA Notes

“SAN FRANCISCO, CA — October 10, 2005 — The less time it takes vancomycin to kill off strains of methicillin-resistant Staphylococcus aureus (MRSA), the more quickly the antibiotic will work in the infected patients. Researchers presented these findings here October 7th at the 43rd annual meeting of the Infectious Diseases Society of America (IDSA).

In patients with MRSA bacteremia, in vitro activity was significantly related to the time to bacterial eradication, probability of microbiologic success, and all-cause mortality," said Pamela Moise-Broder, PharmD, a researcher with CPL Associates LLC, Amherst, New York.”

News - Vancomycin In Vitro Killing Time of MRSA Correlates to Patient Outcomes: Presented at IDSA